fda warning letters glp-1 compounding october 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading Trends In FDA FY 2025
Description
GLP-1 medications likeSemaglutideandTirzepatidehelp balance appetite, blood sugar, and energy for steady, sustainable fat loss
The new class of weight-loss medications are hailed as game-changing wonder drugs, but just how safe and effective are they
No hidden fees
Learn why retatrutide causes diarrhea, what clinical trials reveal about GI side effects by dose, and proven strategies to manage digestive issues.
Click for this HIMS stock update.
It will initially be available via private prescription, with NHS use still under NICE review.
